FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/11/037980 [Registered on: 12/11/2021] Trial Registered Prospectively
Last Modified On: 08/05/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To Compare Anaesthetic Effect of intrathecal 1% 2-Chloroprocaine versus ropivacaine 0.5% with Fentanyl in Urological Surgeries. 
Scientific Title of Study   Comparison Of Anaesthetic Effect of intrathecal 1% 2-Chloroprocaine versus ropivacaine 0.5% with Fentanyl in urological surgeries:A Randomized double blind, interventional study, SMS Medical College and Attached group of Hospitals,Jaipur during 2020-2021. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Varsha Kothari 
Designation  Senior Professor 
Affiliation  S.M.S. Medical College and Attached Group Of Hospitals 
Address  Department Of Anaesthesiology, S.M.S. Medical College and Attached Group Of Hospitals, Adarsh Nagar, Jaipur

Jaipur
RAJASTHAN
302004
India 
Phone  9414870228  
Fax    
Email  vkothari66@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Varsha Kothari 
Designation  Senior Professor 
Affiliation  S.M.S. Medical College and Attached Group Of Hospitals 
Address  Department Of Anaesthesiology, S.M.S. Medical College and Attached Group Of Hospitals, Adarsh Nagar, Jaipur

Jaipur
RAJASTHAN
302004
India 
Phone  9414870228  
Fax    
Email  vkothari66@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Aayushi Dadhich 
Designation  Post Graduate Student 
Affiliation  S.M.S. Medical College and Attached Group Of Hospitals 
Address  Department Of Anaesthesiology, S.M.S. Medical College and Attached Group Of Hospitals, Adarsh Nagar, Jaipur

Jaipur
RAJASTHAN
302004
India 
Phone  9414870228  
Fax    
Email  aayushidadhicha@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesiology, S.M.S. Medical College and Attached Group of Hospitals, Jaipur 
 
Primary Sponsor  
Name  Department of Anaesthesiology SMS Medical College and Attached Group of Hospitals Jaipur 
Address  Adarsh Nagar, Jaipur. 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aayushi Dadhich  S.M.S. Medical College and Attached group of Hospitals  Adarsh Nagar, Jaipur.
Jaipur
RAJASTHAN 
9414870228

aayushidadhicha@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
S.M.S. Medical College and Attached group of Hospitals  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N399||Disorder of urinary system, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group A  30 patients will receive intrathecal 1% 2-chloroprocaine with fentanyl. 
Comparator Agent  Group B  30 patients will receive intrathecal 0.5% ropivacaine with fentanyl. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  1.Patients willing to give consent to participate in the study.
2.Patients posted for urological surgeries belonging to ASA grade I and II.
3.Age between 18 and 55 years.
4.Weight between 50 and 75 kg and height between 150 and 180 cms.  
 
ExclusionCriteria 
Details  1.Patients with skin infection at local site.
2.Patients with severe hypovolemia, severe MS, blood coagulopathies.
3.Patients with raised intracranial pressure.
4.Patients allergic to drugs used for study.
5.Failure of spinal anaesthesia, cases in which general anaesthesia will be required. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the difference in mean onset time and duration of motor block in both groups.  To compare the difference in mean onset time and duration of motor block in both groups. 
 
Secondary Outcome  
Outcome  TimePoints 
1.To compare the in degree of motor and sensory block in both groups.
2.To determine difference in change in hemodynamic variables for baseline to 5,10,15,20 mins upto 4 hours post spinal period.
3. Adverse effects if any. 
Time taken from intrathecal injection to achieve highest level of sensory block and modified bromage score 1 to 4 hours post op to check complications if any. 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/11/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  

Intrathecal chloroprocaine can be used as an alternative to long acting local anesthetics such as ropivacaine for urological surgeries requiring short duration and early ambulation with minimum side effects. As we observed in this study that the intrathecal 1% 2-chloroprocaine with fentanyl provides adequate motor blockade and analgesia for day care urological surgeries while 0.5 % ropivacaine with fentanyl provides a greater duration of sensory and motor blockade than chloroprocaine. Furthermore, fentanyl as an adjuvant to both ropivacaine and chloroprocaine enhances the duration of analgesia and stabilizes hemodynamic variables.

 
Close